Literature DB >> 17663522

Intratumoral sampling variability in hepatocellular carcinoma: a case report.

Giancarlo Senes1, Daniela Fanni, Alessandro Cois, Alessandro Uccheddu, Gavino Faa.   

Abstract

The differential diagnosis between hepatocellular carcinoma (HCC) and regenerative liver nodules and other primary liver tumors may be very difficult, particularly when performed on liver biopsies. Difficulties in histological typing may be often minimized by immunohistochemistry. Among the numerous markers proposed, CK18, Hep Par1 and glypican 3 (GPC3) are considered the most useful in HCC diagnosis. Here we report a case of HCC in a 72-year-old male with HBV-related chronic liver disease, characterized by a marked morphological and immunohistochemical intratumoral variability. In this case, tumor grading ranged from areas extremely well differentiated, similar to regenerative nodule, to undifferentiated regions, with large atypical multinucleated cells. While almost all sub nodules were immunostained by Hep Par 1, immunoreactivity for glypican 3 and for Ck18 was patchy, with negative tumor region adjacent to the highly immunoreactive areas. Our case stresses the relevance of sampling variability in the diagnosis of HCC, and indicates that caution should be taken in grading an HCC and in the interpretation of immunohistochemical stains when only small core biopsies from liver nodules are available.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17663522      PMCID: PMC4171180          DOI: 10.3748/wjg.v13.i29.4019

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.

Authors:  A Durnez; C Verslype; F Nevens; J Fevery; R Aerts; J Pirenne; E Lesaffre; L Libbrecht; V Desmet; T Roskams
Journal:  Histopathology       Date:  2006-08       Impact factor: 5.087

2.  Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study.

Authors:  P Van Eyken; R Sciot; A Paterson; F Callea; M C Kew; V J Desmet
Journal:  Hum Pathol       Date:  1988-05       Impact factor: 3.466

3.  Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.

Authors:  B Maharaj; R J Maharaj; W P Leary; R M Cooppan; A D Naran; D Pirie; D J Pudifin
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

4.  The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.

Authors:  Naoko Yamauchi; Akira Watanabe; Michiyo Hishinuma; Ken-Ichi Ohashi; Yutaka Midorikawa; Yasuyuki Morishita; Toshiro Niki; Junji Shibahara; Masaya Mori; Masatoshi Makuuchi; Yoshitaka Hippo; Tatsuhiko Kodama; Hiroko Iwanari; Hiroyuki Aburatani; Masashi Fukayama
Journal:  Mod Pathol       Date:  2005-12       Impact factor: 7.842

5.  Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver.

Authors:  R L Zimmerman; M A Burke; N A Young; C C Solomides; M Bibbo
Journal:  Cancer       Date:  2001-08-25       Impact factor: 6.860

6.  Recent developments in the first detection of hepatocellular carcinoma.

Authors:  Joseph B Lopez
Journal:  Clin Biochem Rev       Date:  2005-08

7.  Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.

Authors:  P Chu; E Wu; L M Weiss
Journal:  Mod Pathol       Date:  2000-09       Impact factor: 7.842

8.  Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1.

Authors:  Takaaki Sugiki; Masakazu Yamamoto; Atsushi Aruga; Ken Takasaki; Masayuki Nakano
Journal:  J Surg Oncol       Date:  2004-11-01       Impact factor: 3.454

9.  Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.

Authors:  C K Ma; R J Zarbo; H F Frierson; M W Lee
Journal:  Am J Clin Pathol       Date:  1993-05       Impact factor: 2.493

10.  Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.

Authors:  Peiguo G Chu; Shin Ishizawa; Emerald Wu; Lawrence M Weiss
Journal:  Am J Surg Pathol       Date:  2002-08       Impact factor: 6.394

View more
  3 in total

1.  Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series.

Authors:  Claudio De Vito; Debashis Sarker; Paul Ross; Nigel Heaton; Alberto Quaglia
Journal:  Virchows Arch       Date:  2017-07-13       Impact factor: 4.064

2.  Cytokeratin 20-positive hepatocellular carcinoma.

Authors:  D Fanni; S Nemolato; R Ganga; G Senes; C Gerosa; P Van Eyken; K Geboes; G Faa
Journal:  Eur J Histochem       Date:  2009-12-29       Impact factor: 3.188

3.  Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma.

Authors:  W Theunissen; D Fanni; S Nemolato; E Di Felice; T Cabras; C Gerosa; P Van Eyken; I Messana; M Castagnola; G Faa
Journal:  Eur J Histochem       Date:  2014-03-11       Impact factor: 3.188

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.